Delivery Order SPE2DB22D3301-SPE2DB24FY1LP

Award Date 2/27/24
Potential Completion Date 2/28/24
Potential Value $3.1K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $3,387.21 to Amerisourcebergen Drug Corp, a for-profit pharmaceutical distribution company. The contract is for the supply of Telmisartan 80 mg tablets, with a completion date of February 13, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp, with a potential value of up to $999,999,999.00 and a performance period through...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract worth $1,845.14 to Amerisourcebergen Drug Corp's Corporate Office Division on June 7, 2024. The contract is for the supply of Telmisartan 80 mg tablets in 30-count packages, with a completion date of June 10, 2024. This delivery order is placed under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which has a ceiling value of up to $999,999,999.00 and runs through December...
The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract worth $4,662.24 to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical distribution company AmerisourceBergen Corporation. The contract is for the delivery of Telmisartan 80 mg tablets by March 7, 2024. This delivery order is issued under a larger indefinite delivery contract (IDC) held by AmerisourceBergen Drug Corp, valued up to $999,999,999.00 through December 2025,...
The Defense Logistics Agency (DLA) awarded a $1,105.65 firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The contract is for the supply of Telmisartan-HCTZ 80-12.5 mg tablets, and has an ultimate completion date of April 5, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with DLA, which serves as the...
The Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order contract worth $2,567.50 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distribution company. The contract is for the delivery of Telmisartan 40 mg tablets in 30 count packages, with a completion date of March 8, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen...
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract worth $16,557.69 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide Telmisartan-HCTZ 80-25 mg tablets in 30-count packages. The contract has a performance period through March 18, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded by DLA to AmerisourceBergen Drug Corp with a potential value of $999,999,999.00 and a performance...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The $4,589.63 contract is for the provision of 4,564,186,162 units of Telmisartan 80 mg tablets. This delivery order falls under a larger indefinite delivery contract (IDC) awarded to AmerisourceBergen Drug Corp, with a potential value of $999,999,999.00 through December 31, 2025. The IDC serves as the primary vehicle for...
The Defense Logistics Agency (DLA) Troop Support Medical awarded a $12,067.81 firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 4,563,740,125 Telmisartan 80 mg tablets. This delivery order was placed under an indefinite delivery contract (IDC) previously awarded to Amerisourcebergen Drug Corp by DLA, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $3,396.73 to AmerisourceBergen Drug Corp, a for-profit pharmaceutical distribution company, to provide Telmisartan-HCTZ 80-25 mg tablets. The delivery order is part of a larger indefinite delivery contract (IDC) awarded by DLA to AmerisourceBergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. This IDC serves as the primary contract vehicle for...
The U.S. Defense Logistics Agency (DLA) awarded a $6,593.82 Delivery Order contract to AmerisourceBergen Drug Corp for the supply of Telmisartan 80 mg tablets. This contract has a period of performance through September 19, 2024 and is a Firm Fixed Price agreement. AmerisourceBergen, a major pharmaceutical distributor, is providing these essential medications to support DLA Troop Support Medical's mission of supplying medical commodities to military treatment facilities and other government...
  • SPE2DB22D3301
    Indefinite Delivery Contract
  • SPE2DB22D3301-SPE2DB24FY1LP
    Delivery Order

The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $3,088.15 to Amerisourcebergen Drug Corp, a subsidiary of the pharmaceutical distribution company Amerisourcebergen Corporation. The contract is for the delivery of Telmisartan 80 mg tablets in 30-count packages, with a completion date of February 28, 2024. This delivery order does not have a set-aside designation and is part of a larger indefinite delivery contract (IDC) between DLA and Amerisourcebergen Drug Corp, with a potential value of up to $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary vehicle for Amerisourcebergen Drug Corp to provide pharmaceuticals and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense.

Generated 6/2/24, 12:56 AM